About one in two women are affected by cystitis during her lifetime, and many suffer from recurrent urinary tract infections.
What You Should Know: – A new investigation by the Private Equity Stakeholder Project (PESP) reveals, for the first time, private equity (PE) investors were
What You Should Know: – The next generation of ethical generative artificial intelligence (GenAI) provides new hope to transform public health; however, advances in technology
Skip Hanson, EVP, Service Delivery at Carenet Health Not all enterprise scheduling solutions are created equal. Before highlighting the features that every health system should
Intuitive Surgical posted strong robotic volume growth in the second quarter and raised its full-year procedure outlook but said patient interest in new weight-loss drugs
In recent times, a concerning trend has emerged in the world of recreational drug use – the proliferation of NBOMes, also known as “fake acid.”
TORONTO, July 18, 2023 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a commercial-focused specialty pharmaceutical company, is pleased
VANCOUVER, British Columbia, July 20, 2023 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on
Oxford, Ohio and Denver, Colorado–(Newsfile Corp. – July 21, 2023) – PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) (“PsyBio” or the “Company“), an intellectual property
Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment